Luo Y, Li Y R
Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Aug 6;56(8):1062-1068. doi: 10.3760/cma.j.cn112150-20220321-00270.
With an increasing incidence rate, ischemic stroke has become a major public health problem. Early and effective secondary prevention is a key strategy for reducing its high morbidity, high recurrence and high mortality. Combined with the clinical phenotypes and imaging features, the application of potential blood biomarkers can provide the scientific basis for early screening and treatment monitoring to assess stroke recurrence risk stratification, then guide individualized secondary prevention. This article describes and analyzes the current clinical application, existing challenge, and the future development model of blood biomarkers in the field of secondary stroke prevention.
